This program is approved by the Florida Board of Pharmacy to meet the educational requirements outlined in Florida Administrative Code Rule 64B16-26.1003 for pharmacists renewing their license for the first time in Florida.
- Intended Audience: Pharmacists
- Universal Activity Number: 0012-0000-21-002-H02-P
- Contact Hours: 1
- Program Fees: $10.00
- Dates Available: 01/11/2021 – 01/11/2024
- Activity Type: Knowledge
Pharmacists can play a critical role in the care of persons living with human immunodeficiency virus (HIV). This activity will provide an overview of the medications used in the treatment of HIV. Specifically, discussed will be the different classes of antiretrovirals, including the mechanism of action, common side effects, drug-drug interactions, and limitations or special considerations which are unique to specific agents. Also described are the current treatment recommendations for initiating HIV drug therapy with antiretrovirals. Additionally, we will review Florida law as it pertains to HIV testing, including partner notification, privilege to warn, and testing in pregnant women.
At the completion of this activity, the participant will be able to:
- Describe current treatment recommendations for initiating HIV drug therapy with antiretrovirals.
- Describe common side effects (adverse drug reactions), drug‐drug interactions of each, and identify any limitations or special considerations that are unique to particular agents.
- Review Florida law as it pertains to HIV testing, including partner notification.
Disclosure Statement: None of our speakers, reviewers, or planning committee members have disclosed that he/she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.
Please review the resources below before registering for the course.
The University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.